HSCS (STOCKS)
HeartSciences Inc. Common Stock
$1.990000
-0.090000 (-4.33%)
Prev close: $2.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Andrew Christopher Simpson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.34M
- Employees
- 12
- P/E (TTM)
- -0.42
- P/B (TTM)
- 2.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$-0.63 | $-0.87 | +0.2370 | +27.34% |
|
Dec 2025 (Q2)
|
$-0.85 | $-2.01 | +1.1645 | +57.81% |
|
Sep 2025 (Q1)
|
$-1.58 | $-1.94 | +0.3580 | +18.47% |
|
Jun 2025 (Q4)
|
$-1.88 | $-2.30 | +0.4150 | +18.08% |
Financial Statements
| Revenues | $8.67K |
| Cost Of Revenue | $3.65K |
| Gross Profit | $5.02K |
| Nonoperating Income/Loss | -$688.44K |
| Operating Expenses | $7.80M |
| Selling, General, and Administrative Expenses | $4.51M |
| Research and Development | $3.29M |
| Operating Income/Loss | -$7.80M |
| Income/Loss From Continuing Operations After Tax | -$8.49M |
| Income/Loss From Continuing Operations Before Tax | $6.68M |
| Net Income/Loss | -$8.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.49 |
| Basic Average Shares | 2,497,495 |
| Assets | $7.55M |
| Current Assets | $5.10M |
| Inventory | $657.29K |
| Prepaid Expenses | $181.92K |
| Other Current Assets | $4.26M |
| Noncurrent Assets | $2.46M |
| Fixed Assets | $46.07K |
| Intangible Assets | $1.66M |
| Other Non-current Assets | $752.43K |
| Liabilities | $4.90M |
| Current Liabilities | $4.27M |
| Accounts Payable | $410.73K |
| Other Current Liabilities | $3.86M |
| Noncurrent Liabilities | $633.48K |
| Equity | $2.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.65M |
| Liabilities And Equity | $7.55M |
| Net Cash Flow From Operating Activities | -$7.34M |
| Net Cash Flow From Operating Activities, Continuing | -$7.34M |
| Net Cash Flow From Investing Activities | -$52.26K |
| Net Cash Flow From Investing Activities, Continuing | -$52.26K |
| Net Cash Flow From Financing Activities | $8.19M |
| Net Cash Flow From Financing Activities, Continuing | $8.19M |
| Net Cash Flow | $800.51K |
| Net Cash Flow, Continuing | $800.51K |
| Comprehensive Income/Loss | -$8.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.49M |
| Other Comprehensive Income/Loss | $0.00 |